Aims and Scope of Bioorganic and Medicinal Chemistry Letters
Bioorganic & Medicinal Chemistry Letters is a scientific journal focusing on the results of research on the molecular structure of biological organisms and the interaction of biological targets with chemical agents. It is published by Elsevier, which also publishes Bioorganic & Medicinal Chemistry for longer works. Less
Key Metrics
CiteScore 

5
Impact Factor 

< 5
SJR 

Q3Biochemistry

SNIP 

0.75
Recommended pre-submission checks
Powered by 

Topics Covered on Bioorganic and Medicinal Chemistry Letters
Bioorganic and Medicinal Chemistry Letters Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
SJR
| Overview | |
| Publisher | PERGAMON-ELSEVIER SCIENCE LTD |
| Language | English |
| Frequency | Semi-monthly |
| General Details |
View less
Planning to publish in Bioorganic and Medicinal Chemistry Letters ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Bioorganic and Medicinal Chemistry Letters
Design, synthesis, and biological evaluation of sphingosine kinase 2 inhibitors derived from K145.
- 1 Sep 2026
- Bioorganic & medicinal chemistry letters
Design and synthesis of [1,2,4]triazolo[3,4-b]thiadiazine-1,2,4-oxadiazoles as EGFR tyrosine kinase inhibitors.
- 1 Sep 2026
- Bioorganic & medicinal chemistry letters
Design, synthesis and antibacterial evaluation of novel unsaturated butenolide-fatty amine hybrids against multidrug-resistant pathogens.
- 1 Sep 2026
- Bioorganic & medicinal chemistry letters
New thiazole-biaryls as small molecule immunomodulators (SMIs) targeting PD-1/PD-L1 axis.
- 1 Sep 2026
- Bioorganic & medicinal chemistry letters
Synthesis and preliminary enzymatic evaluation of polyol-based 4-phenylbutyrate derivatives.
- 1 Sep 2026
- Bioorganic & medicinal chemistry letters
Biological evaluation of guanidines, bisguanidines, and their derivatives as anti-Trypanosoma cruzi agents.
- 1 Sep 2026
- Bioorganic & medicinal chemistry letters
Design, synthesis, and biological evaluation of sphingosine kinase 2 inhibitors derived from K145.
- 1 Sep 2026
- Bioorganic & medicinal chemistry letters
Design and synthesis of [1,2,4]triazolo[3,4-b]thiadiazine-1,2,4-oxadiazoles as EGFR tyrosine kinase inhibitors.
- 1 Sep 2026
- Bioorganic & medicinal chemistry letters
Design, synthesis and antibacterial evaluation of novel unsaturated butenolide-fatty amine hybrids against multidrug-resistant pathogens.
- 1 Sep 2026
- Bioorganic & medicinal chemistry letters
New thiazole-biaryls as small molecule immunomodulators (SMIs) targeting PD-1/PD-L1 axis.
- 1 Sep 2026
- Bioorganic & medicinal chemistry letters
Synthesis and preliminary enzymatic evaluation of polyol-based 4-phenylbutyrate derivatives.
- 1 Sep 2026
- Bioorganic & medicinal chemistry letters
Biological evaluation of guanidines, bisguanidines, and their derivatives as anti-Trypanosoma cruzi agents.
- 1 Sep 2026
- Bioorganic & medicinal chemistry letters